Litcius/Paper detail

Whole Lung Irradiation for Completely Responding Pulmonary Metastases in Pediatric Ewing Sarcoma

Hagar Elghazawy, Azza Nasr, Iman Zaky, Manal Zamzam, Ahmed Elgammal, Nesma Farid, Mohamed S. Zaghloul

2020Future Oncology16 citationsDOI

Abstract

Aim: Scarce data assessing the real value of whole lung irradiation (WLI) in Ewing’s sarcoma (ES) with lung-only metastasis, with published conflicting results. We studied the impact of WLI in a homogenous pediatric population. Materials & methods: Retrospective study evaluating the survival outcomes of WLI in these patients. Results: Out of 163 metastatic ES; 41 patients were eligible for WLI. 30 patients (73.1%) received WLI (+ve) while 11 patients (26.8%) did not receive WLI (-ve). Five-year event-free survival was statistically significant in WLI (+ve). Five-year pulmonary relapse-free survival showed trend for improvement with WLI (+ve), while 5-year overall survival was not statistically significant between the two arms. Conclusion: WLI added significantly to the long term clinical outcome of metastatic ES patients, with no irreversible toxicity.

Topics & Concepts

MedicineOverall survivalLungSarcomaInternal medicineOncologyPathologySarcoma Diagnosis and TreatmentNeuroblastoma Research and TreatmentsTesticular diseases and treatments
Whole Lung Irradiation for Completely Responding Pulmonary Metastases in Pediatric Ewing Sarcoma | Litcius